FDA Experts To Convene For March Panel To Discuss Dermal Fillers

The US agency will hold a meeting of its plastic surgery devices panel to discuss risks associated with, and patient preference for, dermal fillers.

Close-up of a woman getting injected in the face with a dermal filler by a doctor in medical gloves.

The benefit-risk profile of a popular cosmetic treatment will be on the agenda at a 23 March virtual meeting of the US Food and Drug Administration’s General and Plastic Surgery Devices Panel, the agency announced on 16 February.

The meeting, which will be the first for the panel since 2019, is set to focus on dermal fillers. The...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Regulation

More from Policy & Regulation